Summary Background Cisplatin is used to treat a wide range of childhood cancers and cisplatin-induced hearing loss (CIHL) is a common and debilitating toxicity. We aimed to address persistent knowledge gaps in CIHL by establishing benchmarks for the prevalence of and...
MINNEAPOLIS (WCCO) — The University of Minnesota on Thursday announced that a promising new brain cancer clinical trial is underway. It’s Phase I of the first-in-human trial, and university physicians and scientists are enrolling patients with glioblastoma, which is...
By Dr. Paul Camarata – Clinical Service Chief, Neurosurgery, The University of Kansas Health System Brain tumors are understandably perceived as quite a grim diagnosis. Medical, surgical and technical advances, along with discoveries in research, provide more options...
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows. The study is the first to demonstrate an...
No matter where you are in your journey, CBTF is here to help. If you’re interested in finding out more about CBTF programming and support, please fill out our form to be connected to our team.
